Our data reveal that CASR polymorphisms at rs1801725 but not at rs1801726 SNP are associated with calcium and suggest that polymorphisms at rs1801725 in about 20% of BC cases, underlie, at least in part, the previously reported association of high circulating calcium with BC progression into larger and/or aggressive tumors. The gene discussed is CASR; the disease is breast cancer.